ArticleEuropean journal of medicinal chemistry2018

Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Miryam Pastor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.